Skip to main content

Table 1 Clinical features of the whole study population across different PPARγ2 and ACE I/D genotypes

From: PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome

    All subjects
  Pro12Ala ACE I/D
  PP (334) XA (30) p DD (137) ID (172) II (55) p
Age (years) 56 ± 13 53 ± 10 0.200 56 ± 12 55 ± 14 56 ± 13 0.805
BMI (kg/m2) 30.6 ± 5.7 33.2 ± 6.3 0.015 31.3 ± 6.3 30.4 ± 5.4 30.9 ± 5.5 0.402
WAIST (cm) 98.4 ± 13.9 100.1 ± 13.8 0.528 99.8 ± 14.5 97.5 ± 13.2 98.7 ± 14.2 0.360
Fat Mass (kg) 30.1 ± 11.9 35.7 ± 13.1 0.016 31.1 ± 12.8 29.9 ± 11.6 31.1 ± 12.2 0.644
Glucose (mmol/L) 6.5 ± 2.6 5.9 ± 2.3 0.271 6.7 ± 2.9 6.2 ± 2.3 6.5 ± 2.5 0.22
Insulin (μUI/L)* 7.8 (5.1-12.2) 10.1 (8.0-15.6) 0.284 8.0 (6.0-11.7) 7.9 (5.0-13.0) 8.9 (5.3-14.5) 0.338
HOMA Insulin Resistance* 2.1 (1.3-3.4) 2.3 (1.9-3.6) 0.668 2.1 (1.5-3.3) 2.1 (1.2-3.5) 2.4 (1.3 -3.9) 0.816
Systolic Blood Pressure (mmHg) 134.1 ± 17.4 126.8 ± 17.2 0.033 132.3±17.1 134.7±18.1 132.6±16.3 0.486
Diastolic Blood Pressure (mmHg) 82.4 ± 8.5 81.6 ± 10.6 0.637 82.4 ± 9.2 82.6 ± 8.3 81.2 ± 8.5 0.612
Total Cholesterol (mmol/L) 5.6 ± 1.4 5.9 ± 1.1 0.245 5.8 ± 1.4 5.7 ± 1,4 5.3 ± 1,2 0.1
Triglyceride (mmol/L)* 1.46 (1.04-2.07) 1.32 (0.99-1.93) 0.566 1.54 (1.13-2.15) 1.4 (0.99-2.01) 1.43 (0.97-2.0) 0.41
HDL cholesterol (mmol/L) 1.3 ± 0.4 1.4 ± 0.3 0.595 1.3 ± 0.4 1.3 ± 0.4 1.4 ± 0.3 0.92
LDL Cholesterol (mmol/L) 3.5 ± 1.3 3.8 ± 1.1 0.199 3.6 ± 1.2 3.6 ± 1.3 3.2 ± 1.1 0.16
  1. *Median (Interquartile range)